Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of M606102 (glycopyrronium tosylate) in primary axillary hyperhidrosis
jRCT2080224741Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of glycopyrronium tosylate in essential axillary hyperhidrosis (2 arms), sponsored by Maruho Co., Ltd. Primary endpoints: Long-term efficacy of M606102 and Long-term safety and tolerability of M606102. Started Jun 2019; status: completed.
02
Drugs
glycopyrronium tosylate
03
Conditions
essential axillary hyperhidrosis
Beyond the preview
Go deeper on jRCT2080224741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224741.